Statements (70)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:psychologist
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Sleep_Disorders
|
| gptkbp:affects |
gptkb:Person
sleep quality adults |
| gptkbp:associated_with |
sleep disturbances
family history |
| gptkbp:caused_by |
gptkb:beer
fatigue stress caffeine |
| gptkbp:genetic_diversity |
family history
|
| gptkbp:healthcare |
gptkb:historical_event
sleep disorders anxiety disorders periodic limb movement disorder |
| gptkbp:historical_context |
first described in 1945
previously known as Willis-Ekbom disease |
| https://www.w3.org/2000/01/rdf-schema#label |
Restless Legs Syndrome
|
| gptkbp:impact |
mental health
quality of life daily functioning |
| gptkbp:is_known_for |
gptkb:Willis-Ekbom_disease
|
| gptkbp:is_popular_in |
5-10% of the population
|
| gptkbp:manager |
gptkb:stadium
medication adherence massages hot baths |
| gptkbp:premiered_on |
can occur at any age
|
| gptkbp:provides_information_on |
gptkb:American_Academy_of_Sleep_Medicine
gptkb:European_Sleep_Research_Society gptkb:National_Institute_for_Health_and_Care_Excellence |
| gptkbp:public_awareness |
increasing
increased in recent years |
| gptkbp:research |
clinical trials for new treatments
ongoing studies on genetics studies on pathophysiology |
| gptkbp:research_focus |
genetic studies
treatment efficacy pathophysiology |
| gptkbp:risk_factor |
gptkb:Company
age alcohol consumption chronic diseases obesity pregnancy smoking kidney failure medication side effects caffeine consumption neuropathy gender (more common in women) |
| gptkbp:social_responsibility |
clinical evaluation
DSM-5 criteria ICD-10 code ICD-11 code IRLSSG criteria sleep study |
| gptkbp:symptoms |
peripheral neuropathy
iron deficiency uncomfortable sensations in the legs urge to move the legs relief with movement unpleasant sensations in legs urge to move legs worsening at night |
| gptkbp:treatment |
lifestyle changes
iron supplements dopaminergic agents |